Legal cannabis businesses are urging Texas politicians and legislators to regulate the state’s CBD market.
Texas politicians and legislators are receiving calls to regulate their state’s cannabidiol (CBD) market. Nico Richardson, who is the CEO of Texas Original, one of the largest legal medical cannabis dispensaries in Texas, is urging Governor Greg Abbott and other state legislators to oversee the transactions of hemp-derived CBD products (1). This also would include Delta-8 and Delta-9 tetrahydrocannabinol (THC). Richardson (1) has commented on the matter and said that “the state's unregulated hemp market has created a public health crisis, citing a spike in drug-related offenses in Texas schools and the abundance of young patients involved in calls to the Texas Poison Center Network.”
In the Lone Star State, they have a small-scale Compassionate Use program (2). The program was created to allow doctors who have been approved to “legally prescribe low-levels of THC” (1) for health conditions such as, post-traumatic stress disorder (PTSD), epilepsy, and cancer. It is intensely regulated which has caused concern in other areas cannabis merchandise is sold and not kept a closer eye on.
Despite having this intensely regulated program, throughout the state, a consumer can purchase unregulated CBD products or CBD-derived THC products lie Delta-8 and Delta-9 from gas stations and vape enterprises (1).
Axios Dallas (1) reported that the “federal Food and Drug Administration has warned that some manufacturers may use unsafe chemicals to convert CBD into Delta-8 — and that children might be particularly vulnerable to the effects.” According to the National Cannabis Industry Association (1,3), Delta-8 is banned in 17 states throughout the US. Results from a September 2023 lawsuit have kept Delta-8 THC legal in the state of Texas (1,4).
The Texas Original CEO has further commented on the harms of Texas’s unregulated cannabis market by explaining how “third-party testing has demonstrated that hemp flower products in Texas being sold to minors test well above the legal limit for THC and include potentially harmful pesticides and microbial contaminants,” (1).
“It is long past time for our governor and state Legislature to work together to create a safe and effective regulatory framework for hemp products,” Richardson expressed to Axios (1). “If the Texas Legislature wants to legalize recreational marijuana, they should pass legislation to that effect and develop a regulatory framework to keep these products from kids. What they shouldn't do is turn a blind eye to an unregulated marijuana market that lacks crucial age minimums and consumer protections that exist in other states.”
References
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.